Traditional HCC staging, such as Barcelona clinic liver cancer (BCLC) stage and American Joint Committee on Cancer (AJCC) TNM stage, and serum alpha-fetoprotein (AFP) are currently being widely used to guide clinical practice6,7. This evidence concerns the gene AFP and hepatocellular carcinoma.